IP Verse

Wilding patent opposition analysis

The comprehensive analysis of Wilding opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wilding

Stay updated with the latest patent oppositions filed by Wilding

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3645553
Tropism-Modified Recombinant Viral Particles And Uses Thereof For The Targeted Introduction Of Genetic Material Into Human CellsREGENERON PHARMACEUTICALSDec 14, 2023JG OPPOSITIONS
EP3549601
Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 AntigensWYETHNov 23, 2021JG OPPOSITIONS
EP3616720
Pharmaceutical Composition For Cancer TreatmentSHIONOGINov 16, 2021ABBVIE
EP3099333
Bag3 As A Target For Therapy Of Heart FailureTEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONAug 18, 2021JG OPPOSITIONS
EP3252160
Crispr-Cas Component Systems, Methods And Compositions For Sequence ManipulationTHE ROCKEFELLER UNIVERSITYJul 28, 2021JG OPPOSITIONS
EP2976101
Method Of TreatmentGLAXOSMITHKLINEMay 18, 2021SANOFI PASTEUR
EP2349332
Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6THE GENERAL HOSPITALJul 23, 2020MATHYS & SQUIRE
EP3011032
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic CellsTHE BROAD INSTITUTEJul 16, 2020MATHYS & SQUIRE
EP3360964
Crispr-Based Genome Modification And RegulationSIGMA ALDRICHJul 2, 2020MATHYS & SQUIRE
EP3011034
Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral ComponentsPRESIDENT AND FELLOWS OF HARVARD COLLEGEMay 7, 2020MATHYS & SQUIRE

Top clients of Wilding

Top companies who are the clients of Wilding

CompanyTotal
MATHYS & SQUIRE21
JG OPPOSITIONS7
ABBVIE2
SANOFI PASTEUR2